- Home
- HSBC vs MRK Comparison
HSBC vs MRK Comparison
Compare HSBC & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSBC
- MRK
- Stock Information
- Founded
- HSBC 1865
- MRK 2000
- Country
- HSBC United Kingdom
- MRK United States
- Employees
- HSBC N/A
- MRK N/A
- Industry
- HSBC Savings Institutions
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- HSBC Finance
- MRK Health Care
- Exchange
- HSBC Nasdaq
- MRK Nasdaq
- Market Cap
- HSBC 226.5B
- MRK 218.8B
- IPO Year
- HSBC N/A
- MRK N/A
- Fundamental
- Price
- HSBC $67.33
- MRK $87.34
- Analyst Decision
- HSBC Buy
- MRK Buy
- Analyst Count
- HSBC 1
- MRK 14
- Target Price
- HSBC N/A
- MRK $103.54
- AVG Volume (30 Days)
- HSBC 1.4M
- MRK 13.8M
- Earning Date
- HSBC 10-28-2025
- MRK 10-30-2025
- Dividend Yield
- HSBC 4.87%
- MRK 3.70%
- EPS Growth
- HSBC N/A
- MRK 20.41
- EPS
- HSBC 1.00
- MRK 6.49
- Revenue
- HSBC $56,208,000,000.00
- MRK $63,616,000,000.00
- Revenue This Year
- HSBC $11.34
- MRK $1.84
- Revenue Next Year
- HSBC $1.09
- MRK $5.24
- P/E Ratio
- HSBC $67.47
- MRK $13.49
- Revenue Growth
- HSBC N/A
- MRK 1.82
- 52 Week Low
- HSBC $43.81
- MRK $73.31
- 52 Week High
- HSBC $72.21
- MRK $111.58
- Technical
- Relative Strength Index (RSI)
- HSBC 43.46
- MRK 59.06
- Support Level
- HSBC $70.64
- MRK $86.20
- Resistance Level
- HSBC $71.92
- MRK $91.00
- Average True Range (ATR)
- HSBC 0.67
- MRK 2.23
- MACD
- HSBC -0.34
- MRK 0.64
- Stochastic Oscillator
- HSBC 3.13
- MRK 72.32
About HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates in more than 50 countries with more than 200,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).